Mortality rates in incident ESRD patients figure 9 Mortality rates in incident ESRD patients figure 9.1 adjusted 1st year death rates adjusted for age, gender, race, & primary diagnosis

Mortality rates in prevalent ESRD patients figure 9 Mortality rates in prevalent ESRD patients figure 9.2 adjusted 1st year death rates are adjusted for age, gender, race, & primary diagnosis

Death rates in period prevalent dialysis patients age 65+, by primary diagnosis figure 9.3, 2000, unadjusted

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, 1999, unadjusted figure 9.4, period prevalent general Medicare & period prevalent dialysis pts Patients by cardiovascular disease

Geographic variations in all-cause mortality rates in patients age 65+, by patient population figure 9.5, period prevalent general Medicare & period prevalent dialysis pts General Medicare Deaths per 1,000 patient years 58.2+ (59.2) 56.5 to <58.2 55.0 to <56.5 52.9 to <55.0 below 52.9 (51.1)

Geographic variations in all-cause mortality rates in patients age 65+, by patient population figure 9.5, period prevalent general Medicare & period prevalent dialysis pts Dialysis Deaths per 1,000 patient years 377+ (390) 365 to <377 353 to <365 339 to <353 below 339 (324)

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by diabetic status figure 9.6, period prevalent patients, 1999, unadjusted

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by gender figure 9.7, period prevalent patients, 1999, unadjusted

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by age: 0-44 & 45-64 figure 9.8, period prevalent patients, 1999, unadjusted

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by age: 65-74 & 75+ figure 9.8, period prevalent patients, 1999, unadjusted (cont.)

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, all & white figure 9.9, period prevalent patients, 1999, unadjusted

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, Native Am. & Asian figure 9.9, period prevalent patients, 1999, unadjusted Cardiovascular disease No cardiovascular

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, black figure 9.9, period prevalent patients, 1999, unadjusted 450 350 250 150 50 Cardiovascular disease No cardiovascular Non-CKD CKD Dialysis Non-CKD CKD Dialysis

All-cause mortality in the general Medicare & dialysis populations, patients age 65+, Hispanic figure 9.9, period prevalent patients, 1999, unadjusted 450 350 250 150 50 Cardiovascular disease No cardiovascular

Mortality rates, by age, race/ethnicity, & gender figure 9 Mortality rates, by age, race/ethnicity, & gender figure 9.10, adjusted for diabetic status, eGFR, & BMI

Mortality rates, by age, race/ethnicity, & gender figure 9 Mortality rates, by age, race/ethnicity, & gender figure 9.10, adjusted for diabetic status, eGFR, & BMI (cont.)

Relative risk of mortality (with 95% confidence interval) table 9 Relative risk of mortality (with 95% confidence interval) table 9.a, incidence dialysis patients, 1998-1999 combined

Mortality rates, by estimated glomerular filtration rate & race figure 9.11, adjusted for age, diabetic status, & BMI Deaths per 1,000 patient years

Mortality rates, by estimated glomerular filtration rate, ethnicity & gender figure 9.11, adjusted for age, diabetic status & BMI (cont.) Deaths per 1,000 patient years

Mortality rates, by body mass index & race figure 9 Mortality rates, by body mass index & race figure 9.12, adjusted for age, diabetic status & eGFR Deaths per 1,000 patient years

Mortality rates, by body mass index, ethnicity & gender figure 9 Mortality rates, by body mass index, ethnicity & gender figure 9.12, adjusted for age, diabetic status & eGFR Deaths per 1,000 patient years

Mortality rates in diabetics, by age, race, & gender figure 9 Mortality rates in diabetics, by age, race, & gender figure 9.13, adjusted for eGFR & BMI Deaths per 1,000 patient years Age group

Mortality rates in diabetics, by age, ethnicity, & gender figure 9 Mortality rates in diabetics, by age, ethnicity, & gender figure 9.13, adjusted for eGFR & BMI Deaths per 1,000 patient years Age group

Mortality rates in non-diabetics, by age, race & gender figure 9 Mortality rates in non-diabetics, by age, race & gender figure 9.13, adjusted for eGFR & BMI (cont.) Non-diabetic Deaths per 1,000 patient years Age group

Mortality rates in non-diabetics, by age, ethnicity & gender figure 9 Mortality rates in non-diabetics, by age, ethnicity & gender figure 9.13, adjusted for eGFR & BMI (cont.) Non-diabetic Deaths per 1,000 patient years Age group

Relative risk of all-cause mortality (with 95% confidence interval) by gender* table 9.b, incident hemodialysis patients, 1998-1999 combined *Survive the period 4-9 months post ESRD 1st date with factors defined in the entry period or from the ME form, follow-up 1 yr

Relative risk of all-cause mortality (with 95% confidence interval) by race* table 9.c, incident hemodialysis patients, 1998-1999 combined *Survive the period 4-9 months post ESRD 1st date with factors defined in the entry period or from the ME form, follow-up 1 yr

Relative risk of all-cause mortality (with 95% confidence interval) by diabetic status* table 9.d, incident hemodialysis patients, 1998-1999 combined *Survive the period 4-9 months post ESRD 1st date with factors defined in the entry period or from the ME form, follow-up 1 yr

One-year mortality rates, by hemoglobin, gender, race, & diabetic status* figure 9.14, adjusted for age, ethnicity, BMI, & URR *Survive the period 4-9 months post ESRD 1st date with factors defined in the entry period or from the ME form, follow-up 1 yr

One-year mortality rates, by URR, gender, race, & diabetic status One-year mortality rates, by URR, gender, race, & diabetic status* figure 9.15, adjusted for age, ethnicity, BMI, & hemoglobin *Survive the period 4-9 months post ESRD 1st date with factors defined in the entry period or from the ME form, follow-up 1 yr

Mortality rates, by urea reduction ratio, race/ethnicity, & body mass index: white figure 9.16, adjusted for age, gender, diabetic status, & hemoglobin

Survival curves by age & gender: IgA nephro Survival curves by age & gender: IgA nephro./Berger’s, IgM nephropathy figure 9.17, incident dialysis patients, 1980-2000 combined Months of survival

Survival curves by age & gender: Goodpasture’s syndrome figure 9 Survival curves by age & gender: Goodpasture’s syndrome figure 9.18, incident dialysis patients, 1980-2000 combined

Survival curves by age & gender: lupus erythematosus (SLE nephritis) figure 9.19, incident dialysis patients, 1980-2000 combined

Survival curves by age & gender: other secondary GN/vasculitis figure 9.20, incident dialysis patients, 1980-2000 combined

Survival curves by age & gender: scleroderma figure 9 Survival curves by age & gender: scleroderma figure 9.21, incident dialysis patients, 1980-2000 combined

Survival curves by age & gender: Alport’s, other hereditary/familial disease figure 9.22, incident dialysis patients, 1980-2000 combined

Survival curves by age & gender: Multiple myeloma & light chain nephropathy figure 9.23, incident dialysis pts, 1980-2000, adjusted for age, gender, & race

Survival curves, by age & gender: AIDS nephropathy figure 9 Survival curves, by age & gender: AIDS nephropathy figure 9.24, incident dialysis patients, 1980-2000 combined, adjusted for age, gender, & race

Expected remaining lifetimes (years) of dialysis & transplant patients table 9.e, ESRD data: prevalent dialysis & transplant patients, 2000

Expected remaining lifetimes (years) of the general population table 9 Expected remaining lifetimes (years) of the general population table 9.e, 1999, from the National Vital Statistics Reports

Expected remaining lifetimes in patients with increasing morbidity, by age figure 9.25, chronic kidney disease & diabetes, prevalent dialysis patients, 2000

Expected remaining lifetimes in patients with increasing morbidity, by age figure 9.26, diabetes, chronic kidney disease, & chronic heart

Geographic variations in expected remaining lifetimes: age 0-19, dialysis figure 9.27, prevalent dialysis pts, 2000, by state, unadjusted Years 20.5+ (21.3) 19.6 to <20.5 19.1 to <19.6 18.5 to <19.1 below 185 (175)

Geographic variations in expected remaining lifetimes: age 0-19, transplant figure 9.27, prevalent transplant pts, 2000, by state, unadjusted Years 50.9 + (53.6) 49.2 to <50.9 47.6 to <49.2 46.2 to <47.6 below 46.2 (43.7)

Geographic variations in expected remaining lifetimes: age 0-19, general Medicare figure 9.27, 2000, unadjusted Years 57.8+ (60.6) 56.9 to <57.8 54.5 to <56.9 52.4 to <54.5 below 52.4 (49.7)

Geographic variations in expected remaining lifetimes: age 20-44, dialysis figure 9.27, prevalent dialysis patients, 2000, unadjusted Years 12.0+ (12.5) 11.3 to <12.0 11.0 to <11.3 10.6 to <11.0 below 10.6 (9.7)

Geographic variations in expected remaining lifetimes: age 20-44, transplant figure 9.27, prevalent transplant patients, 2000, unadjusted Years 35.2+ (37.5) 33.1 to <35.2 32.5 to <33.1 31.3 to <32.5 below 31.3 (29.2)

Geographic variations in expected remaining lifetimes: age 20-44, general Medicare figure 9.27, 2000, unadjusted Years 41.7+ (43.6) 41.1 to <41.7 39.7 to <41.1 38.3 to <39.7 below 38.3 (36.6)

Geographic variations in expected remaining lifetimes: age 45-64, dialysis figure 9.27, prevalent dialysis patients, 2000, unadjusted Years 6.0+ (6.3) 5.8 to <6.0 5.5 to <5.8 5.2 to <5.5 below 5.2 (4.8)

Geographic variations in expected remaining lifetimes: age 45-64, transplant figure 9.27, prevalent transplant patients, 2000, unadjusted Years 19.6+ (21.3) 18.0 to <19.6 17.6 to <18.0 16.7 to <17.6 below 16.7 (15.2)

Geographic variations in expected remaining lifetimes: age 45-64, general Medicare figure 9.27, 2000, unadjusted Years 25.3+ (26.3) 24.7 to <25.3 24.1 to <24.7 23.4 to <24.1 below 23.4 (22.8)

Geographic variations in expected remaining lifetimes: age 65+, dialysis figure 9.27, prevalent dialysis patients, 2000, unadjusted Years 3.0+ (3.1) 2.9 to <3.0 2.8 to <2.9 2.7 to <2.8 below 2.7 (2.5)

Geographic variations in expected remaining lifetimes: age 65+, transplant figure 9.27, prevalent transplant patients, 2000, unadjusted Years 11.1+ (12.3) 10.0 to <11.1 9.7 to <10.0 9.0 to <9.7 below 9.0 (8.0)

Geographic variations in expected remaining lifetimes: age 65+, general Medicare figure 9.27, 2000, unadjusted Years 15.1+ (15.6) 14.9 to <15.1 14.8 to <14.9 14.3 to <14.8 below 14.3 (14.0)